Use of an activator of glucose uptake to reduce post-ischemic injury of the heart.

A use of 5- [4- [2- (N-methyl-N- (2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2,4-dione (Compound (I)), or a tautomeric form thereof or a pharmaceutically acceptable derivative thereof, for producing a medicament for reducing post-ischemic injury in the heart of a non-diabetic human and / or improving the functional recovery of the heart of a non-diabetic human following of myocardial ischemia.